NCR Graphs - All Cancers

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
J01DD01	STOPAREN	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	213,671 L.L
J01DD04	ROCEPHIN IV	B	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	757,927 L.L
J01XA02	TARGOCID	B	Teicoplanin - 400mg	400mg	Injectable lyophilised powder for solution+diluent	1,331,748 L.L
J01DD04	ROCEPHIN IM	B	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	731,050 L.L
J01XA02	TARGOCID	B	Teicoplanin - 200mg	200mg	Injectable lyophilised powder for solution+diluent	714,924 L.L
J01DD04	CEFAXONE IV	G	Ceftriaxone - 1g	1g	Injectable lyophilised powder for solution+diluent	403,153 L.L
H01AB01	THYROGEN	BioHuman	Thyrotropin alfa - 0.9mg	0.9mg	Injectable lyophilised powder for solution+diluent	65,558,997 L.L
J01DD04	TRAVILAN IM	G	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	438,093 L.L
J01DD04	VERACOL	G	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	454,219 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	3,420,079 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	21,354,452 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	21,354,452 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	3,420,079 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable lyophilised powder for solution+diluent	52,297,174 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 400mg	400mg	Injectable lyophilised powder for solution+diluent	450,187 L.L
H02AB09	SOLU CORTEF ACT-O-VIAL	B	Hydrocortisone (sodium succinate) - 250mg	250mg	Injectable lyophilised powder for solution+diluent	421,967 L.L
L02AE04	DECAPEPTYL	B	Triptorelin - 0.1mg	0.1mg	Injectable lyophilised powder for solution+diluent	2,366,507 L.L
G03GA01	CHORIOMON	BioHuman	Human Chorionic Gonadotrophin - 5,000IU	5,000IU	Injectable lyophilised powder for solution+diluent	4,031,528 L.L
G03GA04	FOSTIMON	BioHuman	Urofollitropin - 150IU	150IU	Injectable lyophilised powder for solution+diluent	36,347,120 L.L
G03GA04	FOSTIMON	BioHuman	Urofollitropin - 75IU	75IU	Injectable lyophilised powder for solution+diluent	15,744,000 L.L
J07AH08	NIMENRIX	B	Polysaccharide of Neisseria meningitidis (serogroups A, C, Y and W-135) conjugated - 5mcg/0.5ml, Tetanus toxoid carrier protein - 44mcg/0.5ml		Injectable lyophilised powder for solution+diluent	4,483,059 L.L
M01AC02	SORAL	G	Tenoxicam - 20mg/2ml	20mg/2ml	Injectable lyophilised powder for solution+solvent	588,603 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	239,484,334 L.L
B03BA51	DEPOVEX	B	Aluminium monostearate - 20mg/ml, Cyanocobalamine - 1mg/ml		Injectable oily suspension	423,310 L.L
J01DB04	CEFAZOL IM/IV	G	Cefazolin (sodium) - 1g	1g	Injectable powder	5,375,370 L.L
L01BA04	PEMETREXED NEAPOLIS	G	Pemetrexed (disodium) - 500mg		Injectable powder	41,289,202 L.L
J01DD04	CEFAXONE	G	Ceftriaxone - 1g	1g	Injectable powder	403,153 L.L
L01BC07	AZACITIDINE SPC	G	Azacitidine - 100mg	100mg	Injectable powder	10,706,993 L.L
L01FX02	MYLOTARG	BioTech	Gemtuzumab Ozogamicin - 4.5mg	4.5mg	Injectable powder	748,160,090 L.L
H02AB09	HYDROCORTISONE ORBUCELL	G	Hydrocortisone (sodium succinate) - 100mg	100mg	Injectable powder	1,091,712 L.L

رسومات بيانية لسجل الوطني للسرطان - نسب الحدوث حسب السنوات